Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

Celldex Therapeutics Stock News

CLDXNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

Celldex Therapeutics (CLDX) Forecast

News

Earnings Celldex Therapeutics (CLDX) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest Celldex Therapeutics Stock News | NASDAQ:CLDX | Benzinga

Get the latest news on Celldex Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Celldex Therapeutics performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Thursday, March 20, 2025

7 Analysts Have This To Say About Celldex Therapeutics
Benzinga Insights - Mar 20, 2025, 6:00PM
This Microsoft Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Avi Kapoor - Mar 20, 2025, 9:55AM
Morgan Stanley Initiates Coverage On Celldex ...
Benzinga Newsdesk - Mar 20, 2025, 6:53AM

Monday, March 03, 2025

Goldman Sachs Maintains Neutral on Celldex Th...
Benzinga Newsdesk - Mar 3, 2025, 9:45AM
Celldex Therapeutics Presents Preclinical Dat...
Benzinga Newsdesk - Mar 3, 2025, 8:05AM
HC Wainwright & Co. Reiterates Buy on Celldex...
Benzinga Newsdesk - Mar 3, 2025, 6:42AM
On Saturday, Celldex Therapeutics Announced D...
Benzinga Newsdesk - Mar 3, 2025, 5:06AM

Friday, February 28, 2025

Forecasting The Future: 6 Analyst Projections For Celldex Therapeutics
Benzinga Insights - Feb 28, 2025, 7:01AM
HC Wainwright & Co. Reiterates Buy on Celldex...
Benzinga Newsdesk - Feb 28, 2025, 6:43AM

Thursday, February 27, 2025

Celldex Expects Cash And Equivalents Sufficie...
Benzinga Newsdesk - Feb 27, 2025, 4:30PM
Celldex Therapeutics Q4 2024 GAAP EPS $(0.71)...
Benzinga Newsdesk - Feb 27, 2025, 4:29PM

Tuesday, February 18, 2025

Baidu, Informatica And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Avi Kapoor - Feb 18, 2025, 8:12AM

Thursday, February 13, 2025

UBS Initiates Coverage On Celldex Therapeutic...
Benzinga Newsdesk - Feb 13, 2025, 9:18AM

Wednesday, January 29, 2025

Demystifying Celldex Therapeutics: Insights From 6 Analyst Reviews
Benzinga Insights - Jan 29, 2025, 2:05PM
Cantor Fitzgerald Reiterates Overweight on Ce...
Benzinga Newsdesk - Jan 29, 2025, 9:47AM

Wednesday, January 08, 2025

Jasper Therapeutics Skin Disorder Candidate Data Fails To Cheer Investors
Vandana Singh - Jan 8, 2025, 10:23AM

Thursday, January 02, 2025

Cantor Fitzgerald Reiterates Overweight on Ce...
Benzinga Newsdesk - Jan 2, 2025, 8:34AM

Friday, December 20, 2024

What Analysts Are Saying About Celldex Therapeutics Stock
Benzinga Insights - Dec 20, 2024, 8:02AM
HC Wainwright & Co. Reiterates Buy on Celldex...
Benzinga Newsdesk - Dec 20, 2024, 7:27AM

Thursday, December 19, 2024

HC Wainwright & Co. Reiterates Buy on Celldex...
Benzinga Newsdesk - Dec 19, 2024, 11:51AM
Celldex Launches Phase 2 Study Of Barzolvolim...
Benzinga Newsdesk - Dec 19, 2024, 8:12AM

Wednesday, November 20, 2024

Celldex Therapeutics Doses First Patient In P...
Benzinga Newsdesk - Nov 20, 2024, 8:03AM
Beyond The Numbers: 11 Analysts Discuss Celldex Therapeutics Stock
Benzinga Insights - Nov 20, 2024, 7:00AM
HC Wainwright & Co. Reiterates Buy on Celldex...
Benzinga Newsdesk - Nov 20, 2024, 6:11AM

Thursday, November 07, 2024

HC Wainwright & Co. Reiterates Buy on Celldex...
Benzinga Newsdesk - Nov 7, 2024, 3:15PM

Monday, October 28, 2024

Analyst Expectations For Celldex Therapeutics's Future
Benzinga Insights - Oct 28, 2024, 2:01PM
HC Wainwright & Co. Reiterates Buy on Celldex...
Benzinga Newsdesk - Oct 28, 2024, 1:13PM

Friday, October 25, 2024

Celldex Announces Upcoming Late Breaking Oral...
Benzinga Newsdesk - Oct 25, 2024, 8:27AM

Monday, October 07, 2024

Citigroup Initiates Coverage On Celldex Thera...
Benzinga Newsdesk - Oct 7, 2024, 11:00AM

Monday, September 30, 2024

Goldman Sachs Initiates Coverage On Celldex T...
Benzinga Newsdesk - Sep 30, 2024, 6:39AM

Friday, September 27, 2024

This HP Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
Avi Kapoor - Sep 27, 2024, 8:46AM
Wolfe Research Downgrades Celldex Therapeutic...
Benzinga Newsdesk - Sep 27, 2024, 5:45AM

Thursday, September 26, 2024

HC Wainwright & Co. Reiterates Buy on Celldex...
Benzinga Newsdesk - Sep 26, 2024, 6:35AM

Wednesday, September 25, 2024

A Closer Look at 10 Analyst Recommendations For Celldex Therapeutics
Benzinga Insights - Sep 25, 2024, 1:01PM
Wolfe Research Reiterates Outperform on Celld...
Benzinga Newsdesk - Sep 25, 2024, 12:06PM
Celldex Therapeutics shares are trading lower...
Benzinga Newsdesk - Sep 25, 2024, 11:26AM
Celldex Therapeutics Shares Resumed Trade
Benzinga Newsdesk - Sep 25, 2024, 11:09AM
Chief Medical Officer Diane C. Young, Of Cell...
Benzinga Newsdesk - Sep 25, 2024, 11:02AM
Celldex Therapeutics Reports Safety Concerns ...
Benzinga Newsdesk - Sep 25, 2024, 11:01AM
Celldex Therapeutics Presents 52-Week Results...
Benzinga Newsdesk - Sep 25, 2024, 10:47AM

Friday, September 20, 2024

Cantor Fitzgerald Reiterates Overweight on Ce...
Benzinga Newsdesk - Sep 20, 2024, 12:13PM

Wednesday, September 18, 2024

Cantor Fitzgerald Reiterates Overweight on Ce...
Benzinga Newsdesk - Sep 18, 2024, 9:18AM

Monday, September 16, 2024

Cantor Fitzgerald Reiterates Overweight on Ce...
Benzinga Newsdesk - Sep 16, 2024, 11:35AM
Celldex Announces Upcoming Late Breaking Oral...
Benzinga Newsdesk - Sep 16, 2024, 8:33AM

Monday, September 09, 2024

The Analyst Verdict: Celldex Therapeutics In The Eyes Of 7 Experts
Benzinga Insights - Sep 9, 2024, 1:00PM
Cantor Fitzgerald Reiterates Overweight on Ce...
Benzinga Newsdesk - Sep 9, 2024, 11:34AM

Monday, August 12, 2024

Wells Fargo Maintains Equal-Weight on Celldex...
Benzinga Newsdesk - Aug 12, 2024, 1:45PM
7 Analysts Have This To Say About Celldex Therapeutics
Benzinga Insights - Aug 12, 2024, 8:01AM
HC Wainwright & Co. Reiterates Buy on Celldex...
Benzinga Newsdesk - Aug 12, 2024, 6:07AM

Thursday, August 08, 2024

Celldex Therapeutics Q2 EPS $(0.54) Beats $(0...
Benzinga Newsdesk - Aug 8, 2024, 5:08PM

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved